At our recent Annual General Meeting, Prof Beverland reported that recruitment is underway for our TRAC-24 clinical trial, with over a 130 patients already recruited.
During a hip or knee replacement it is not unusual for a patient to lose almost a third of the total blood in their body. This study hopes to find out the best way of giving tranexamic acid to help reduce blood loss. The study will cost over £600,000 and is the largest of its kind so far in the world. It is hoped that as well as having a direct beneficial effect on the patient as less blood is lost, it will also significantly reduce the requirement for blood transfusions – a major issue for the NHS.